Literature DB >> 20713680

Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan.

Te-Li Chen1, Yi-Tzu Lee, Shu-Chen Kuo, Po-Ren Hsueh, Feng-Yee Chang, Leung-Kei Siu, Wen-Chien Ko, Chang-Phone Fung.   

Abstract

The bla(OXA-51)-like gene with an upstream ISAba1 (ISAba1-bla(OXA-51)-like gene) was originally found on the chromosomes of carbapenem-resistant or -susceptible Acinetobacter baumannii isolates. However, a plasmid-borne ISAba1-bla(OXA-51)-like gene has recently been identified in Acinetobacter genomic species 13TU and several A. baumannii isolates in Taiwan, and all of the isolates are carbapenem resistant. This study aimed to characterize the plasmids bearing the ISAba1-bla(OXA-51)-like gene and their significance in A. baumannii. Among the 117 ISAba1-bla(OXA-51)-like-harboring isolates collected from 10 hospitals in Taiwan, 58 isolates (49.6%) from 24 clones had the genes located on plasmids that likely originated from a common progenitor. Among the 58 isolates, four had additional copy of the ISAba1-bla(OXA-51)-like gene on their chromosomes. Based on the analysis of these four isolates, the plasmid-located ISAba1-bla(OXA-51)-like gene appeared to be acquired via one-ended transposition (Tn6080). The isolates with a plasmid bearing the ISAba1-bla(OXA-51)-like gene had higher rates of resistance to imipenem (98% versus 46.6%; P < 0.001) and meropenem (98% versus 69%; P = 0.019) than those with the genes chromosomally encoded, which is most likely due to increased gene dosage provided by the higher copy number of associated plasmids. Transformation with a recombinant plasmid harboring only the ISAba1-bla(OXA-51)-like gene was enough to confer a high level of carbapenem resistance to A. baumannii, eliminating the possible contribution of other factors on the original plasmids. This study demonstrated that the carbapenem resistance-associated plasmids carrying the ISAba1-bla(OXA-51)-like gene are widespread in A. baumannii strains in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713680      PMCID: PMC2976157          DOI: 10.1128/AAC.00764-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

2.  Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases.

Authors:  Matthew J Ellington; James Kistler; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2006-12-21       Impact factor: 5.790

3.  Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species.

Authors:  Jane F Turton; Neil Woodford; Judith Glover; Susannah Yarde; Mary E Kaufmann; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 4.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 6.  OXA (beta)-lactamases in Acinetobacter: the story so far.

Authors:  Susan Brown; Sebastian Amyes
Journal:  J Antimicrob Chemother       Date:  2005-12-06       Impact factor: 5.790

7.  Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to beta-lactams.

Authors:  Hedi Mammeri; Laurent Poirel; Nicole Mangeney; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

8.  Is IS(ABA-1) customized for Acinetobacter?

Authors:  Heidi Segal; Seike Garny; B Gay Elisha
Journal:  FEMS Microbiol Lett       Date:  2005-02-15       Impact factor: 2.742

9.  Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory.

Authors:  Clare Franklin; Lisa Liolios; Anton Y Peleg
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

10.  VIM-1 metallo-beta-lactamase in Acinetobacter baumannii.

Authors:  Athanassios Tsakris; Alexandros Ikonomidis; Spyros Pournaras; Leonidas S Tzouvelekis; Danai Sofianou; Nicholas J Legakis; Antonios N Maniatis
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more
  58 in total

1.  Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation.

Authors:  Shweta Fulsundar; Klaus Harms; Gøril E Flaten; Pål J Johnsen; Balu Ananda Chopade; Kaare M Nielsen
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

2.  The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.

Authors:  Cynthia M June; Taylor J Muckenthaler; Emma C Schroder; Zachary L Klamer; Zdzislaw Wawrzak; Rachel A Powers; Agnieszka Szarecka; David A Leonard
Journal:  Protein Sci       Date:  2016-09-26       Impact factor: 6.725

3.  Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D β-Lactamases.

Authors:  Clyde A Smith; Nuno Tiago Antunes; Nichole K Stewart; Hilary Frase; Marta Toth; Katherine A Kantardjieff; Sergei Vakulenko
Journal:  ACS Chem Biol       Date:  2015-06-12       Impact factor: 5.100

4.  Identification of blaOXA-₅₁-like, blaOXA-₅₈, blaDIM-₁, and blaVIM carbapenemase genes in hospital Enterobacteriaceae isolates from Sierra Leone.

Authors:  Tomasz A Leski; Umaru Bangura; David H Jimmy; Rashid Ansumana; Stephen E Lizewski; Robert W Li; David A Stenger; Chris R Taitt; Gary J Vora
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

5.  Identification of Acinetobacter baumannii of Human and Animal Origins by a Gene-Specific PCR.

Authors:  Ahmed Hamouda
Journal:  Curr Microbiol       Date:  2017-06-29       Impact factor: 2.188

6.  Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii.

Authors:  Rodrigo Cayô; María-Cruz Rodríguez; Paula Espinal; Felipe Fernández-Cuenca; Alain A Ocampo-Sosa; Alvaro Pascual; Juan A Ayala; Jordi Vila; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

7.  Plasmid Profile Analysis and bla VIM Gene Detection of Metalo β-lactamase (MBL) Producing Pseudomonas aeruginosa Isolates from Clinical Samples.

Authors:  Jayanthi S; Jeya M
Journal:  J Clin Diagn Res       Date:  2014-06-20

8.  Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.

Authors:  Joshua M Mitchell; David A Leonard
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

9.  Characterization and genome sequencing of phage Abp1, a new phiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii.

Authors:  Guangtao Huang; Shuai Le; Yizhi Peng; Yan Zhao; Supeng Yin; Lin Zhang; Xinyue Yao; Yinling Tan; Ming Li; Fuquan Hu
Journal:  Curr Microbiol       Date:  2013-01-18       Impact factor: 2.188

10.  Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  Patricia J Simner; J Kristie Johnson; William B Brasso; Karen Anderson; David R Lonsway; Virginia M Pierce; April M Bobenchik; Zabrina C Lockett; Angella Charnot-Katsikas; Lars F Westblade; Brian B Yoo; Stephen G Jenkins; Brandi M Limbago; Sanchita Das; Darcie E Roe-Carpenter
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.